Growth Metrics

Usana Health Sciences (USNA) Retained Earnings (2016 - 2026)

Usana Health Sciences has reported Retained Earnings over the past 16 years, most recently at -$14.4 million for Q2 2026.

  • Quarterly Retained Earnings fell 103.02% to -$14.4 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was -$14.4 million through Apr 2026, down 103.02% year-over-year, with the annual reading at $465.7 million for FY2026, 2154.34% up from the prior year.
  • Retained Earnings was -$14.4 million for Q2 2026 at Usana Health Sciences, down from $465.7 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $477.6 million in Q1 2025 and troughed at -$22.7 million in Q4 2024.
  • The 5-year median for Retained Earnings is $354.3 million (2022), against an average of $252.6 million.
  • The largest YoY upside for Retained Earnings was 38166.11% in 2022 against a maximum downside of 105.72% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$12.8 million in 2022, then skyrocketed by 3581.79% to $445.2 million in 2023, then crashed by 105.09% to -$22.7 million in 2024, then grew by 14.91% to -$19.3 million in 2025, then rose by 25.16% to -$14.4 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Retained Earnings are -$14.4 million (Q2 2026), $465.7 million (Q1 2026), and -$19.3 million (Q3 2025).